70 FR 245 pgs. 76058-76060 - Advisory Committees; Tentative Schedule of Meetings for 2006
Type: NOTICEVolume: 70Number: 245Pages: 76058 - 76060
FR document: [FR Doc. E5-7645 Filed 12-21-05; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version: PDF Version
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Advisory Committees; Tentative Schedule of Meetings for 2006
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice.
SUMMARY:
The Food and Drug Administration (FDA) is announcing a tentative schedule of forthcoming meetings of its public advisory committees for 2006. During 1991, at the request of the Commissioner of Food and Drugs (the Commissioner), the Institute of Medicine (the IOM) conducted a study of the use of FDA's advisory committees. In its final report, one of the IOM's recommendations was for the agency to publish an annual tentative schedule of its meetings in the Federal Register . This publication implements the IOM's recommendation.
FOR FURTHER INFORMATION CONTACT:
Theresa L. Green, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.
SUPPLEMENTARY INFORMATION:
The IOM, at the request of the Commissioner, undertook a study of the use of the FDA's advisory committees. In its final report in 1992, one of the IOM's recommendations was for FDA to adopt a policy of publishing an advance yearly schedule of its upcoming public advisory committee meetings in the Federal Register ; FDA has implemented this recommendation. The annual publication of tentatively scheduled advisory committee meetings will provide both advisory committee members and the public with the opportunity, in advance, to schedule attendance at FDA's upcoming advisory committee meetings. Because the schedule is tentative, amendments to this notice will not be published in the Federal Register . However, changes to the schedule will be posted on the FDA advisory committees' Internet site located at http://www.fda.gov/oc/advisory/default.htm . FDA will continue to publish a Federal Register notice 15 days in advance of each upcoming advisory committee meeting, to announce the meeting (21 CFR 14.20).
The following list announces FDA's tentatively schedule advisory committee meeting for 2006. You may also obtain up-to-date information by calling the Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area).
Committee Name | Tentative Date(s) of Meetings | Advisory Committee 10-Digit Information Line Code |
---|---|---|
OFFICE OF THE COMMISSIONER | ||
Pediatric Advisory Committee | March, June, and November day(s) to be announced. | 8732310001 |
Science Board to the Food and Drug Administration | April and November day(s) to be announced. | 3014512603 |
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH | ||
Allergenic Products Advisory Committee | March 31, September 13. | 3014512388 |
Blood Products Advisory Committee | March 9-10, July 13-14, October 26-27. | 3014519516 |
Cellular, Tissue and Gene Therapies Advisory Committee | February 9-10, July 13-14, November 2-3. | 3014512389 |
Transmissible Spongiform Encephalopathies Advisory Committee | To be announced. | 3014512392 |
Vaccines and Related Biological Products Advisory Committee | February 17, May 17-18, September 20-21, November 15-16. | 3014512391 |
CENTER FOR DRUG EVALUATION AND RESEARCH | ||
Anesthetic and Life Support Drugs Advisory Committee | To be announced. | 3014512529 |
Anti-Infective Drugs Advisory Committee | To be announced. | 3014512530 |
Antiviral Drugs Advisory Committee | To be announced. | 3014512531 |
Arthritis Advisory Committee | To be announced. | 3014512532 |
Cardiovascular and Renal Drugs Advisory Committee | April 25-26, July 25-26, November 1-2. | 3014512533 |
Dermatologic and Ophthalmic Drugs Advisory Committee | To be announced. | 3014512534 |
Drug Safety and Risk Management Advisory Committee | February 9-10, May 4-5. | 3014512535 |
Endocrinologic and Metabolic Drugs Advisory Committee | January 23, May 3-4, August 23-24, November 8-9. | 3014512536 |
Gastrointestinal Drugs Advisory Committee | September and November day(s) to be announced. | 3014512538 |
Nonprescription Drugs Advisory Committee | January 23-24. | 3014512541 |
Oncologic Drugs Advisory Committee | March 14 (Pediatric Subcommittee), March 15, June 2, September 12-13, December 6-7. | 3014512542 |
Peripheral and Central Nervous System Drugs Advisory Committee | March 7-8. | 3014512543 |
Pharmaceutical Science, Advisory Committee for | April 13-14 (Clinical Pharmacology Subcommittee), October 18-19 (Clinical Pharmacology Subcommittee), April, May, and October day(s) to be announced. | 3014512539 |
Psychopharmacologic Drugs Advisory Committee | To be announced. | 3014512544 |
Pulmonary-Allergy Drugs Advisory Committee | January 24. | 3014512545 |
Reproductive Health Drugs, Advisory Committee for | May and June day(s) to be announced. | 3014512537 |
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH | ||
Device Good Manufacturing Practice Advisory Committee | No tentative meeting scheduled. | 3014512398 |
Medical Devices Advisory Committee (Comprised of 18 Panels) | ||
Anesthesiology and Respiratory Therapy Devices Panel | April 7, October 6. | 3014512624 |
Circulatory System Devices Panel | February 16, April 21, June 16, August 18, October 20. | 3014512625 |
Clinical Chemistry and Clinical Toxicology Devices Panel | February 22-23, May 24-25, September 7-8, December 6-7. | 3014512514 |
Dental Products Panel | February 28, July 25, October 24. | 3014512518 |
Ear, Nose, and Throat Devices Panel | February 1-2, April 3-4, June 15-16, August 10-11, October 11-12, December 4-5. | 3014512522 |
Gastroenterology-Urology Devices Panel | March 3, May 5, July 21, October 20. | 3014512523 |
General and Plastic Surgery Devices Panel | April 27-28, August 24-25, December 4-5. | 3014512519 |
General Hospital and Personal Use Devices Panel | February 9-10, June 12-13, September 28-29. | 3014512520 |
Hematology and Pathology Devices Panel | April 28, October 20. | 3014512515 |
Immunology Devices Panel | July 14, November 8. | 3014512516 |
Medical Devices Dispute Resolution Panel | Meeting scheduled as needed. | 3014510232 |
Microbiology Devices Panel | February 23-24, September 21-22, October 26-27. | 3014512517 |
Molecular and Clinical Genetics Panel | April 13-14, October 5-6. | 3014510231 |
Neurological Devices Panel | March 2-4, August 3-4, June 5-6, August 28-29, November 13-14. | 3014512513 |
Obstetrics-Gynecology Devices Panel | March 27-28, June 5-6, August 28-29, November 13-14. | 3014512524 |
Ophthalmic Devices Panel | March 7-8, May 18, July 13-14, September 19-20, November 2-3. | 3014512396 |
Orthopaedic and Rehabilitation Devices Panel | February 2-3, July 27-28, October 26-27, December 11-12. | 3014512521 |
Radiological Devices Panel | February 7, May 23, September 12, November 7. | 3014512526 |
National Mammography Quality Assurance Advisory Committee | August 28. | 3014512397 |
Technical Electronic Product Radiation Safety Standards Committee | October 4. | 3014512399 |
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION | ||
Food Advisory Committee | March 1, May 3, July 12, September 13. | 3014510564 |
CENTER FOR VETERINARY MEDICINE | ||
Veterinary Medicine Advisory Committee | March 15, October 16. | 3014512548 |
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH (NCTR) | ||
Science Advisory Board to NCTR | April day(s) to be announced. | 3014512559 |
Advisory Committee on Special Studies Relating to the Possible Long-Term Health Effects of Phenoxy Herbicides and Contaminants (Ranch Hands) | February day(s) to be announced. | 3014512560 |
Dated: December 14, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. E5-7645 Filed 12-21-05; 8:45 am]
BILLING CODE 4160-01-S